Therapeutic efficacy of INX-315, a selective CDK2 inhibitor, in solid tumors [OVCAR3 RNAseq]
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
We performed RNA sequencing on OVCAR3 parental cells treated with either control vehicle for 4 days or 300 nM INX-315 for 7 days. OVCAR3 parental cells were treated with either control DMSO for 4 days or 300 nM INX-315 for 7 days. 3 replicates per group were collected.
创建时间：
2025-05-06
